

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.48763469 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.48763469 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.96013881 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 5.94051310 |
| 5 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.73822315 |
| 6 | * response to type I interferon (GO:0034340) | 5.65385145 |
| 7 | * cellular response to type I interferon (GO:0071357) | 5.62657931 |
| 8 | * type I interferon signaling pathway (GO:0060337) | 5.62657931 |
| 9 | regulation of interferon-alpha production (GO:0032647) | 5.62619879 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.42095569 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.42095569 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.42095569 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.42095569 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.42095569 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 5.42095569 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.28562714 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.08753399 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.80374819 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.80374819 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.57494787 |
| 21 | cellular response to virus (GO:0098586) | 4.54617458 |
| 22 | response to interferon-alpha (GO:0035455) | 4.50825742 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.47660921 |
| 24 | response to peptidoglycan (GO:0032494) | 4.34203813 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.33611826 |
| 26 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.27763876 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 4.21782400 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 4.19087990 |
| 29 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.18115645 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.15413481 |
| 31 | response to host immune response (GO:0052572) | 4.15413481 |
| 32 | positive regulation of interferon-beta production (GO:0032728) | 4.09951559 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 4.06620860 |
| 34 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.98690182 |
| 35 | detection of other organism (GO:0098543) | 3.94376375 |
| 36 | * negative regulation of viral genome replication (GO:0045071) | 3.93988728 |
| 37 | detection of bacterium (GO:0016045) | 3.87069190 |
| 38 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.85304202 |
| 39 | * regulation of viral genome replication (GO:0045069) | 3.84289099 |
| 40 | cellular response to interferon-beta (GO:0035458) | 3.79123866 |
| 41 | response to interferon-beta (GO:0035456) | 3.77432641 |
| 42 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.76386690 |
| 43 | regulation of RIG-I signaling pathway (GO:0039535) | 3.75745761 |
| 44 | response to host (GO:0075136) | 3.71363404 |
| 45 | response to host defenses (GO:0052200) | 3.71363404 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.71363404 |
| 47 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.68953691 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.67741840 |
| 49 | regulation of antigen processing and presentation (GO:0002577) | 3.65277687 |
| 50 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.63628795 |
| 51 | regulation of type 2 immune response (GO:0002828) | 3.61369436 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.60077346 |
| 53 | respiratory burst (GO:0045730) | 3.58967494 |
| 54 | granulocyte activation (GO:0036230) | 3.58933102 |
| 55 | * negative regulation of viral process (GO:0048525) | 3.58326647 |
| 56 | natural killer cell activation involved in immune response (GO:0002323) | 3.58203112 |
| 57 | T cell migration (GO:0072678) | 3.57026542 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 3.55963283 |
| 59 | B cell mediated immunity (GO:0019724) | 3.55415958 |
| 60 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.50008128 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.49725084 |
| 62 | neutrophil activation (GO:0042119) | 3.48975893 |
| 63 | response to exogenous dsRNA (GO:0043330) | 3.46744899 |
| 64 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.46377393 |
| 65 | defense response to protozoan (GO:0042832) | 3.45486529 |
| 66 | natural killer cell mediated immunity (GO:0002228) | 3.42590002 |
| 67 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.42590002 |
| 68 | positive regulation of interleukin-17 production (GO:0032740) | 3.42440651 |
| 69 | positive regulation of interleukin-12 production (GO:0032735) | 3.39917361 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39041710 |
| 71 | * cellular response to interferon-gamma (GO:0071346) | 3.37742466 |
| 72 | negative regulation of type 2 immune response (GO:0002829) | 3.37007945 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.35614849 |
| 74 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.31598600 |
| 75 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.31598600 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.27139841 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.26379635 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.25724573 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.25529832 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 3.25464848 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.24817136 |
| 82 | detection of external biotic stimulus (GO:0098581) | 3.23996721 |
| 83 | cellular response to interferon-alpha (GO:0035457) | 3.23526307 |
| 84 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19680882 |
| 85 | leukocyte aggregation (GO:0070486) | 3.16490744 |
| 86 | positive regulation of type 2 immune response (GO:0002830) | 3.16329352 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14514736 |
| 88 | regulation of interleukin-17 production (GO:0032660) | 3.13747210 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13324825 |
| 90 | * defense response to virus (GO:0051607) | 3.12882213 |
| 91 | interferon-gamma secretion (GO:0072643) | 3.11998375 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 3.11153239 |
| 93 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.10555639 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 3.10024188 |
| 95 | negative regulation of innate immune response (GO:0045824) | 3.09820536 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.09536330 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 3.09028812 |
| 98 | positive regulation of humoral immune response (GO:0002922) | 3.08958712 |
| 99 | response to protozoan (GO:0001562) | 3.08630880 |
| 100 | regulation of interferon-beta production (GO:0032648) | 3.08167558 |
| 101 | germinal center formation (GO:0002467) | 3.08117941 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06882081 |
| 103 | * response to interferon-gamma (GO:0034341) | 3.06599682 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04277127 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03758855 |
| 106 | negative regulation of type I interferon production (GO:0032480) | 3.02160689 |
| 107 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.00368760 |
| 108 | regulation of activation of Janus kinase activity (GO:0010533) | 3.00027851 |
| 109 | response to interleukin-15 (GO:0070672) | 2.99996159 |
| 110 | lymphocyte migration (GO:0072676) | 2.98979460 |
| 111 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98528059 |
| 112 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96961942 |
| 113 | lymphocyte chemotaxis (GO:0048247) | 2.96016696 |
| 114 | regulation of response to interferon-gamma (GO:0060330) | 2.95005665 |
| 115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94349409 |
| 116 | cellular response to exogenous dsRNA (GO:0071360) | 2.93784579 |
| 117 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93675747 |
| 118 | regulation of tolerance induction (GO:0002643) | 2.90557129 |
| 119 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.90510914 |
| 120 | regulation of interleukin-12 production (GO:0032655) | 2.89810603 |
| 121 | microglial cell activation (GO:0001774) | 2.89359716 |
| 122 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.88803553 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.88761683 |
| 124 | negative thymic T cell selection (GO:0045060) | 2.87701263 |
| 125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87220161 |
| 126 | negative regulation of interleukin-17 production (GO:0032700) | 2.85413714 |
| 127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84239067 |
| 128 | regulation of defense response to virus by host (GO:0050691) | 2.83574974 |
| 129 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.83126659 |
| 130 | positive regulation of defense response to virus by host (GO:0002230) | 2.83052781 |
| 131 | regulation of T cell cytokine production (GO:0002724) | 2.82916063 |
| 132 | negative regulation of defense response to virus (GO:0050687) | 2.82566326 |
| 133 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.81657828 |
| 134 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.81274060 |
| 135 | B cell proliferation (GO:0042100) | 2.80050287 |
| 136 | positive regulation of response to biotic stimulus (GO:0002833) | 2.79572736 |
| 137 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78585672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.73187706 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.08813721 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.44571396 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.27420743 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.63131217 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.59273588 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.16763154 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.64243697 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.54089511 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41586931 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36960371 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.32255198 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.13007572 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92572888 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.76966225 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74297708 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.57937746 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34321954 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.12138007 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.08120462 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.96332046 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93170070 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91463631 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90186316 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86074525 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84465730 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80710534 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.75607394 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73152376 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71892909 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71887984 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64541382 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64400553 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64199735 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63398758 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61987097 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60248955 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59983265 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59600780 |
| 40 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58711532 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55578818 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52049151 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51476645 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40889451 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40450611 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34914918 |
| 47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32893840 |
| 48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.28960466 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28913592 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28181040 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27435450 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25244743 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24738218 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21964161 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21120822 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19633443 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16787409 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16018492 |
| 59 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15994457 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13209783 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12615344 |
| 62 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11613157 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10470943 |
| 64 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05753166 |
| 65 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05212213 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05090828 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03816336 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03177860 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01196641 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00484969 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00066049 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.00000283 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99290787 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98761780 |
| 75 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92744584 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92499951 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90476138 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89879284 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86551513 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85913400 |
| 81 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84966566 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84614898 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84603087 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83274004 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80562568 |
| 86 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80216518 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77244359 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77003318 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76370794 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75624409 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75334590 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73467593 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.71934512 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.71366113 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70999422 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70504357 |
| 97 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69048269 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68775310 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.68373126 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67465509 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.67248654 |
| 102 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.65675737 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65057675 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.63980330 |
| 105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62814497 |
| 106 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.62535525 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.61489072 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.60794263 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60386335 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59360404 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58550395 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.58514480 |
| 113 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.57944646 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.56997489 |
| 115 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.56581380 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.56575254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.99255474 |
| 2 | MP0009785_altered_susceptibility_to | 4.20827968 |
| 3 | MP0003436_decreased_susceptibility_to | 3.68189753 |
| 4 | MP0000685_abnormal_immune_system | 3.51398309 |
| 5 | MP0005387_immune_system_phenotype | 3.38601430 |
| 6 | MP0001790_abnormal_immune_system | 3.38601430 |
| 7 | MP0005671_abnormal_response_to | 3.36355286 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.28250915 |
| 9 | MP0005025_abnormal_response_to | 3.23802529 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.22588293 |
| 11 | MP0006082_CNS_inflammation | 3.07545052 |
| 12 | MP0002419_abnormal_innate_immunity | 2.96077761 |
| 13 | MP0003303_peritoneal_inflammation | 2.88883167 |
| 14 | MP0003724_increased_susceptibility_to | 2.87891771 |
| 15 | MP0004510_myositis | 2.87185274 |
| 16 | MP0001800_abnormal_humoral_immune | 2.85087478 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.78421472 |
| 18 | MP0002723_abnormal_immune_serum | 2.76324681 |
| 19 | MP0001819_abnormal_immune_cell | 2.52245787 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.47803607 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.17711324 |
| 22 | MP0004947_skin_inflammation | 2.11872462 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.03433328 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.02054920 |
| 25 | MP0005451_abnormal_body_composition | 2.01865807 |
| 26 | MP0002006_tumorigenesis | 1.99270412 |
| 27 | MP0002405_respiratory_system_inflammati | 1.97357957 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.93749697 |
| 29 | MP0002398_abnormal_bone_marrow | 1.93636134 |
| 30 | MP0000716_abnormal_immune_system | 1.92195735 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.88744303 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.87210988 |
| 33 | MP0005310_abnormal_salivary_gland | 1.84208858 |
| 34 | MP0001853_heart_inflammation | 1.78257881 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.76041849 |
| 36 | MP0008469_abnormal_protein_level | 1.74580270 |
| 37 | MP0003448_altered_tumor_morphology | 1.74458993 |
| 38 | MP0009764_decreased_sensitivity_to | 1.72616771 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.72100956 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.69371625 |
| 41 | MP0009278_abnormal_bone_marrow | 1.61238799 |
| 42 | MP0002429_abnormal_blood_cell | 1.55628994 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.54780946 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.52633345 |
| 45 | MP0002722_abnormal_immune_system | 1.47545745 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.44952707 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.44952707 |
| 48 | MP0010307_abnormal_tumor_latency | 1.43596693 |
| 49 | MP0000343_altered_response_to | 1.37357197 |
| 50 | MP0009840_abnormal_foam_cell | 1.35842153 |
| 51 | MP0001873_stomach_inflammation | 1.34044099 |
| 52 | MP0000858_altered_metastatic_potential | 1.32723713 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.31491054 |
| 54 | MP0003075_altered_response_to | 1.27008322 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.24855105 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.22880226 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.22635775 |
| 58 | MP0002933_joint_inflammation | 1.16462143 |
| 59 | MP0000604_amyloidosis | 1.08795281 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.07307586 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.06697734 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.06637480 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.04922884 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.04777040 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.03218974 |
| 66 | MP0000703_abnormal_thymus_morphology | 0.99076653 |
| 67 | MP0005166_decreased_susceptibility_to | 0.96505191 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92583746 |
| 69 | MP0009763_increased_sensitivity_to | 0.91042268 |
| 70 | MP0004858_abnormal_nervous_system | 0.90608687 |
| 71 | MP0005390_skeleton_phenotype | 0.89423123 |
| 72 | MP0004381_abnormal_hair_follicle | 0.88753647 |
| 73 | MP0000490_abnormal_crypts_of | 0.87665133 |
| 74 | MP0002332_abnormal_exercise_endurance | 0.87366312 |
| 75 | MP0003866_abnormal_defecation | 0.86962559 |
| 76 | MP0004883_abnormal_blood_vessel | 0.86096270 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.85833945 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.84913994 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.84028547 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.79424263 |
| 81 | MP0001348_abnormal_lacrimal_gland | 0.79284439 |
| 82 | MP0002132_abnormal_respiratory_system | 0.75568872 |
| 83 | MP0001851_eye_inflammation | 0.74944642 |
| 84 | MP0008874_decreased_physiological_sensi | 0.73803266 |
| 85 | MP0008260_abnormal_autophagy | 0.71962973 |
| 86 | MP0005164_abnormal_response_to | 0.71857793 |
| 87 | MP0002163_abnormal_gland_morphology | 0.71649749 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.71583650 |
| 89 | MP0003186_abnormal_redox_activity | 0.69371858 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.68506125 |
| 91 | MP0008004_abnormal_stomach_pH | 0.68414931 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.67638517 |
| 93 | MP0003091_abnormal_cell_migration | 0.66203115 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.65953425 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.65401096 |
| 96 | MP0000249_abnormal_blood_vessel | 0.61608919 |
| 97 | MP0005023_abnormal_wound_healing | 0.60559964 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.60248063 |
| 99 | MP0001663_abnormal_digestive_system | 0.59251875 |
| 100 | MP0003795_abnormal_bone_structure | 0.58612463 |
| 101 | MP0000920_abnormal_myelination | 0.57657235 |
| 102 | MP0001881_abnormal_mammary_gland | 0.57414328 |
| 103 | MP0003690_abnormal_glial_cell | 0.57270097 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.56859160 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.55058223 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.54853982 |
| 107 | MP0005621_abnormal_cell_physiology | 0.54372913 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.53266696 |
| 109 | MP0003828_pulmonary_edema | 0.52453478 |
| 110 | MP0003045_fibrosis | 0.52216174 |
| 111 | MP0000609_abnormal_liver_physiology | 0.51616618 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.51133656 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.48074823 |
| 114 | MP0000371_diluted_coat_color | 0.46417353 |
| 115 | MP0002254_reproductive_system_inflammat | 0.44587883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.24877002 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.14680257 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.60699845 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.53935567 |
| 5 | Chronic otitis media (HP:0000389) | 5.45124101 |
| 6 | Myositis (HP:0100614) | 5.08456109 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.86399811 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.78512207 |
| 9 | Orchitis (HP:0100796) | 4.65796501 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.65183028 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.58042674 |
| 12 | Optic neuritis (HP:0100653) | 4.58042674 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.23532339 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.19090170 |
| 15 | Vasculitis (HP:0002633) | 4.05586111 |
| 16 | Increased IgM level (HP:0003496) | 4.04018389 |
| 17 | Nasal polyposis (HP:0100582) | 3.98819502 |
| 18 | Recurrent viral infections (HP:0004429) | 3.83418140 |
| 19 | Stomatitis (HP:0010280) | 3.79573424 |
| 20 | Recurrent skin infections (HP:0001581) | 3.77310411 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.67981971 |
| 22 | Basal ganglia calcification (HP:0002135) | 3.66826185 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.56654628 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.55276000 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.51650618 |
| 26 | Obstructive lung disease (HP:0006536) | 3.51650618 |
| 27 | Gingivitis (HP:0000230) | 3.44660775 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.31374417 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.30942188 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28749357 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28749357 |
| 32 | Pustule (HP:0200039) | 3.19456327 |
| 33 | Hypergammaglobulinemia (HP:0010702) | 3.17650465 |
| 34 | Chronic sinusitis (HP:0011109) | 3.02414006 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.99416754 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.96137882 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 2.94376015 |
| 38 | Prostate neoplasm (HP:0100787) | 2.90196603 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.84317483 |
| 40 | Petechiae (HP:0000967) | 2.83544761 |
| 41 | Meningitis (HP:0001287) | 2.82213187 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82144317 |
| 43 | Hemoptysis (HP:0002105) | 2.79724745 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.78610119 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.75838276 |
| 46 | Periodontitis (HP:0000704) | 2.71106352 |
| 47 | Loss of speech (HP:0002371) | 2.70050929 |
| 48 | Arterial thrombosis (HP:0004420) | 2.69923544 |
| 49 | Increased IgE level (HP:0003212) | 2.66134343 |
| 50 | Urticaria (HP:0001025) | 2.64982008 |
| 51 | Leukocytosis (HP:0001974) | 2.64499990 |
| 52 | Abnormality of the endocardium (HP:0004306) | 2.63561547 |
| 53 | Cellulitis (HP:0100658) | 2.62286352 |
| 54 | Abnormality of T cells (HP:0002843) | 2.61324717 |
| 55 | Gingival bleeding (HP:0000225) | 2.58386189 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.57836342 |
| 57 | Gangrene (HP:0100758) | 2.55910685 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.53687802 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.53604446 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.51119872 |
| 61 | T lymphocytopenia (HP:0005403) | 2.48596290 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.48173848 |
| 63 | Tetraparesis (HP:0002273) | 2.47895805 |
| 64 | Porencephaly (HP:0002132) | 2.47681510 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.46363688 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.43908446 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40565435 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40565435 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40565435 |
| 70 | Eosinophilia (HP:0001880) | 2.40167620 |
| 71 | IgM deficiency (HP:0002850) | 2.35833197 |
| 72 | Anorexia (HP:0002039) | 2.34777813 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.33361706 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32136923 |
| 75 | Joint swelling (HP:0001386) | 2.31985323 |
| 76 | Emphysema (HP:0002097) | 2.30381170 |
| 77 | Pulmonary embolism (HP:0002204) | 2.28060390 |
| 78 | Lymphopenia (HP:0001888) | 2.27618320 |
| 79 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26813289 |
| 80 | Encephalitis (HP:0002383) | 2.25899754 |
| 81 | Peritonitis (HP:0002586) | 2.24885509 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24486565 |
| 83 | Disinhibition (HP:0000734) | 2.24034345 |
| 84 | Osteomyelitis (HP:0002754) | 2.22410562 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.21032930 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.20800827 |
| 87 | IgA deficiency (HP:0002720) | 2.20413812 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.19459017 |
| 89 | IgG deficiency (HP:0004315) | 2.19382158 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.17677455 |
| 91 | Cheilitis (HP:0100825) | 2.14951045 |
| 92 | Granulocytopenia (HP:0001913) | 2.13422495 |
| 93 | Skin rash (HP:0000988) | 2.12832099 |
| 94 | Glomerulopathy (HP:0100820) | 2.12091117 |
| 95 | Axonal loss (HP:0003447) | 2.11699732 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11007336 |
| 97 | Abnormality of the prostate (HP:0008775) | 2.10992144 |
| 98 | Sepsis (HP:0100806) | 2.10653685 |
| 99 | Abnormality of eosinophils (HP:0001879) | 2.10113201 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 2.08408225 |
| 101 | Arthralgia (HP:0002829) | 2.06461917 |
| 102 | Epistaxis (HP:0000421) | 2.05539759 |
| 103 | Skin ulcer (HP:0200042) | 2.05361771 |
| 104 | Chronic diarrhea (HP:0002028) | 2.05298008 |
| 105 | Colitis (HP:0002583) | 2.04966999 |
| 106 | Chest pain (HP:0100749) | 2.04165806 |
| 107 | Fatigue (HP:0012378) | 2.03682846 |
| 108 | Abnormality of the pleura (HP:0002103) | 2.03323959 |
| 109 | Purpura (HP:0000979) | 1.99618921 |
| 110 | Viral hepatitis (HP:0006562) | 1.99096910 |
| 111 | Restrictive lung disease (HP:0002091) | 1.98496736 |
| 112 | Thick nail (HP:0001805) | 1.98003578 |
| 113 | Malnutrition (HP:0004395) | 1.97271949 |
| 114 | Thrombocytosis (HP:0001894) | 1.97153866 |
| 115 | Hypochromic anemia (HP:0001931) | 1.95956729 |
| 116 | Hematochezia (HP:0002573) | 1.95675749 |
| 117 | Keratitis (HP:0000491) | 1.95407751 |
| 118 | Acute hepatic failure (HP:0006554) | 1.94201002 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.92882510 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.92726275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 4.79342860 |
| 2 | IKBKE | 4.24095530 |
| 3 | MAP3K14 | 4.15541156 |
| 4 | TYK2 | 4.13599528 |
| 5 | MAP4K1 | 3.42554527 |
| 6 | JAK3 | 3.15109488 |
| 7 | BLK | 3.04378008 |
| 8 | IRAK4 | 2.93553013 |
| 9 | PRPF4B | 2.86313183 |
| 10 | KIT | 2.85557873 |
| 11 | TXK | 2.61805583 |
| 12 | JAK1 | 2.52978628 |
| 13 | IKBKB | 2.45109765 |
| 14 | RIPK4 | 2.27719839 |
| 15 | FGFR4 | 2.16136773 |
| 16 | MAP3K13 | 2.03355700 |
| 17 | IRAK3 | 1.95960954 |
| 18 | PIM2 | 1.93276158 |
| 19 | ZAP70 | 1.81431939 |
| 20 | ERN1 | 1.78033402 |
| 21 | PBK | 1.75702611 |
| 22 | CSK | 1.61187821 |
| 23 | SYK | 1.54785488 |
| 24 | EPHB1 | 1.51764681 |
| 25 | FGFR3 | 1.50099610 |
| 26 | HCK | 1.43687094 |
| 27 | SMG1 | 1.43331606 |
| 28 | CHUK | 1.40513353 |
| 29 | BTK | 1.37481847 |
| 30 | LCK | 1.25735852 |
| 31 | GRK7 | 1.23457174 |
| 32 | FES | 1.22377287 |
| 33 | CSF1R | 1.21129333 |
| 34 | SIK1 | 1.21031967 |
| 35 | NME2 | 1.15823862 |
| 36 | TAOK3 | 1.14013831 |
| 37 | EPHA3 | 1.12757824 |
| 38 | ARAF | 1.12338798 |
| 39 | TEC | 1.12114752 |
| 40 | PIM1 | 1.10634963 |
| 41 | GRK6 | 1.07802162 |
| 42 | LYN | 1.06173336 |
| 43 | STK10 | 1.05040996 |
| 44 | CDC42BPA | 1.03397413 |
| 45 | SIK3 | 1.02794540 |
| 46 | RPS6KA4 | 1.01074546 |
| 47 | TAOK2 | 1.00311002 |
| 48 | JAK2 | 0.96751809 |
| 49 | MST4 | 0.95826437 |
| 50 | TAOK1 | 0.89717127 |
| 51 | FGR | 0.83028995 |
| 52 | NEK9 | 0.82625006 |
| 53 | STK4 | 0.81675963 |
| 54 | MARK3 | 0.81416859 |
| 55 | HIPK2 | 0.79769496 |
| 56 | EIF2AK2 | 0.78198723 |
| 57 | ITK | 0.78151174 |
| 58 | SIK2 | 0.69092939 |
| 59 | BMX | 0.69011598 |
| 60 | TGFBR2 | 0.68560239 |
| 61 | DDR2 | 0.67591567 |
| 62 | NLK | 0.66389151 |
| 63 | MATK | 0.65645476 |
| 64 | PRKD2 | 0.65384117 |
| 65 | BMPR2 | 0.63449985 |
| 66 | PRKCQ | 0.62806876 |
| 67 | IRAK2 | 0.61812642 |
| 68 | MAP3K11 | 0.61695416 |
| 69 | MAPK7 | 0.59908874 |
| 70 | IRAK1 | 0.57527682 |
| 71 | MAP3K5 | 0.56773014 |
| 72 | PRKCD | 0.55078853 |
| 73 | TRPM7 | 0.53904333 |
| 74 | ABL1 | 0.50556629 |
| 75 | PTK6 | 0.50541015 |
| 76 | KSR2 | 0.49234116 |
| 77 | RPS6KA5 | 0.48262948 |
| 78 | KDR | 0.48170259 |
| 79 | EGFR | 0.47912847 |
| 80 | LRRK2 | 0.47337472 |
| 81 | ABL2 | 0.45945722 |
| 82 | CLK1 | 0.43739575 |
| 83 | MARK2 | 0.42579151 |
| 84 | MAPK11 | 0.39985363 |
| 85 | MAP2K3 | 0.39903707 |
| 86 | ADRBK2 | 0.39043465 |
| 87 | YES1 | 0.38638191 |
| 88 | CDK4 | 0.38195169 |
| 89 | TESK2 | 0.36584102 |
| 90 | PRKG2 | 0.36315731 |
| 91 | MAPKAPK2 | 0.36198606 |
| 92 | MAP3K12 | 0.35133502 |
| 93 | MST1R | 0.34000351 |
| 94 | RPS6KA6 | 0.33698524 |
| 95 | NUAK1 | 0.33262616 |
| 96 | PDK1 | 0.32772345 |
| 97 | MELK | 0.32046815 |
| 98 | MOS | 0.31708729 |
| 99 | TNK2 | 0.31543769 |
| 100 | MAP3K1 | 0.31518554 |
| 101 | CDK12 | 0.30909415 |
| 102 | TGFBR1 | 0.29835226 |
| 103 | PKN1 | 0.29776819 |
| 104 | PDPK1 | 0.29295070 |
| 105 | MAP3K6 | 0.28130426 |
| 106 | TESK1 | 0.27607547 |
| 107 | FLT3 | 0.26808238 |
| 108 | TRIB3 | 0.26138919 |
| 109 | FYN | 0.24943554 |
| 110 | ICK | 0.24579957 |
| 111 | RIPK1 | 0.23614435 |
| 112 | PKN2 | 0.22601754 |
| 113 | PRKCH | 0.21963737 |
| 114 | CDK6 | 0.21602064 |
| 115 | RPS6KA1 | 0.21581514 |
| 116 | STK24 | 0.21000016 |
| 117 | TTN | 0.20706322 |
| 118 | IGF1R | 0.20168467 |
| 119 | MAP3K8 | 0.19934600 |
| 120 | RET | 0.19504189 |
| 121 | MAPK3 | 0.19433013 |
| 122 | MAP3K3 | 0.19045686 |
| 123 | RPS6KC1 | 0.19006075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14617185 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.06062139 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.00650845 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.99471509 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.93929333 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.84004591 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.70581764 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66738197 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44072953 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20689249 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19327033 |
| 12 | * Influenza A_Homo sapiens_hsa05164 | 2.16285973 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15689841 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.10643525 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.08779759 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03080088 |
| 17 | * Herpes simplex infection_Homo sapiens_hsa05168 | 2.01040847 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98034172 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.95355457 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.91160125 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.83943237 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.83524471 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74880466 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69876165 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.66954848 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65796360 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62595843 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62490551 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60183836 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.56564811 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44871603 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44341225 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.43225874 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.43102516 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40870237 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40328977 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39891713 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.39890952 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.37683803 |
| 40 | * Hepatitis C_Homo sapiens_hsa05160 | 1.36270172 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31762039 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.28372418 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.25845080 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23707003 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21765502 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14535872 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07839210 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 1.01033029 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96534643 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92365175 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90850353 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85872002 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82789232 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81094532 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78029088 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76786449 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69434284 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67647478 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66803917 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65336200 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65151577 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63756509 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.61256666 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59755585 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.58991676 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55562438 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55021784 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53323599 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.52048136 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50033992 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49912318 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.49549177 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49526970 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47581497 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45915354 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44007534 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43640717 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42451853 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41503072 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40593924 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38671070 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37663959 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35116996 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34609123 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.34453643 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.34214909 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33694741 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33138739 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32926996 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.32655188 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32161427 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31312428 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28093719 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25761865 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25261264 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23358655 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23291972 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.23011525 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22889530 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22238828 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21574723 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21397716 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20627275 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.19357270 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19311228 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19196370 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15638681 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.11769631 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11549294 |
| 110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11345940 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.11310244 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11206048 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11126020 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11061485 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.09428048 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.07969979 |

